Back to search
FDAFDA · Food and drugs·Recall number D-0569-2022

Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392

Published March 2, 2022 · Recall initiated: February 14, 2022

Summary

FDA records drug Class III recall D-0569-2022, published March 2, 2022 and initiated February 14, 2022. Recalling firm: BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy; Status: Terminated; Reported quantity: 1157 bags; Lot: Lot #: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
Distributor
Florida
Lot
Lot #: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392 recalled?

Yes. FDA published recall D-0569-2022 on March 2, 2022. Reported hazard: Subpotent drug

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit